Company page

Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (ticker: CTKB) is a public company operating in the American market, with a market capitalization of approximately $486.87 million. The company specializes in advanced cell analysis technologies, providing innovative solutions for researchers and clinicians. Cytek aims to enhance the understanding of cellular biology through its cutting-edge products and services.

profileCTKB:NASDAQAI content: aiUpdated June 24, 2026/company/cytek-biosciences-inc/c-joomxktf
Cytek Biosciences, Inc. logo
Ticker
CTKB:NASDAQ
Asset type
Stock
Market cap
$486.9M
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD